Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease
- 1 February 1997
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (3) , 683-686
- https://doi.org/10.1097/00001756-199702100-00021
Abstract
WE examined a deletion/insertion promoter polymorphism of the serotonin transporter gene, which confers an ∼40% reduction in expression of the protein, in 196 subjects with late onset Alzheimer's disease (AD) and 271 controls. The frequency of the 484 bp low activity allele was elevated in the subjects with AD (p = 0.004), and an excess of the low activity genotype (30%) was also found in comparison with the controls (20%) (χ2 = 7.16; p = 0.03). This association was unrelated to the age of the subjects or controls, or to ε4 alleles of the ApoE gene. The odds ratio for the effect of the homozygous low activity genotype was 1.7 (95% CI 1.08–2.67), with a population attributable risk of 33% (95% CI 5–54%). These findings indicate that the low activity allele of the serotonin transporter is a risk factor for late onset AD.Keywords
This publication has 6 references indexed in Scilit:
- The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processesJournal of Molecular Medicine, 1996
- The Camberwell Dementia Case RegisterInternational Journal of Geriatric Psychiatry, 1996
- Altered serotonin transporter sites in Alzheimerʼs disease raphe and hippocampusNeuroReport, 1995
- The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalitiesPsychological Medicine, 1992
- Age Stability of Human Brain 5-HT Terminals Studied with [3H]Paroxetine BindingGerontology, 1992
- Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseTrends in Pharmacological Sciences, 1991